The SARS-CoV-2 Delta variant that caused the third wave of COVID-19 in mid-2021 turned out to be more contagious than earlier SARS-CoV-2 variants. In...
Since the success of the COVID-19 vaccine, RNA therapies have been the object of increasing interest in the biotech world. These therapies work with your...
Vijay Pande, PhD, leads a team of about 40 professionals who oversee Andreessen Horowitz's Bio + Health Fund, which the firm describes as being at the...
Preventive and therapeutic vaccines both train the immune system to fight disease, but they are used in different ways.
Ben Hargreaves speaks to Liberate Bio, a company that is hoping to address the delivery issues that could The post Taking an ‘upside-down’ approach...
The XBB.1.5 subvariant — nicknamed ‘Kraken’ — is arguably the most genetically rich and most transmissible SARS-CoV-2 Omicron subvariant yet.
To understand the potential for machine learning to transform medicine, we must go back to the controversial origins of data use in healthcare
WHO Encourages Mask Wearing On Long-Haul Flights Authored by Mimi Nguyen Ly via The Epoch Times, Countries should consider recommending travelers...
The CEOs of Lumen Bioscience (Brian Finrow) and Eligo Bioscience (Xavier Duportet) share remarkable advancements that need funding, while Khosla Venture’s...
Key trends include fewer and slower financings, a surge of decisive data readouts for cancer vaccines, and further development of mRNA, cell, and gene...
A team of researchers led by The University of Texas MD Anderson Cancer Center has developed a novel delivery system for messenger RNA (mRNA) using extracellular...
Crossing the blood-brain barrier is a familiar challenge in therapeutic applications. And it is increasingly recognized as a challenge for imaging applications,...
At a recent industry event, the 14th Annual Bioprocessing Summit in Boston, scientists discussed a variety of advances in gene therapy manufacturing. To...
PORTLAND, Oregon — Using nanotechnology that enabled mRNA-based COVID-19 vaccines, a new approach to gene therapy may improve how physicians treat...
PORTLAND, Ore. – Oregon State University College of Pharmacy scientists have demonstrated in animal models the possibility of using lipid nanoparticles...
Data suggests the bivalent boosters are working well against omicron.
The COVID-19 pandemic, caused by the SARS CoV-2 virus, continues to threaten populations around the world, after killing over 1 million Americans. In recent...
deCODE has agreed to carry out whole-genome sequencing on the 35,000 samples using Illumina sequencing technologies, and will upload the data to the Illumina...
These Were The Most Important Science Headlines Of 2022 Scientific discoveries and technological innovation play a vital role in addressing...
HOUSTON – (Jan. 6, 2023) – As anyone who has ever attended a cocktail party can tell you, shedding inhibitions makes you more talkative and possibly...
Many microscopy techniques have won Nobel Prizes over the years. Advancements like cryo-ET that allow scientists to see the individual atoms of cells can...
Right up front, I’m going to repeat myself by saying that I think COVID-19 will become a disease that has endemic as well as epidemic states...
After a year of omicron variants, will we ever see a new variant of concern?
In a first for the genetic toolset known as CRISPR, a recently discovered protein has been found to act as a kind of multipurpose self-destruct system...
The proposed EHDS Regulation1 (Proposal), introduced in May 2022 by the European Commission (EC), aims to reform the The post European Health Data Space...
“The thickness of the arrows denotes tighter (thick lines) and weaker (thin lines) links between genetic variants, AD biomarkers, and cognitive impairment.”...
The year’s crop of US drug approvals won’t rival past vintages for quantity. But of the 45 drugs cleared for use by the FDA in 2022,...
NVX-CoV2373 is a protein-based vaccine engineered from the genetic sequence of the first strain of SARS-CoV-2, the virus that causes COVID-19 disease....
China Hit By Tsunami Of COVID Infections In Reopening Scramble But It's All Just Omicron, As No New Variants Emerge There are good and bad...
A biotech working to create an intranasal vaccine booster for the ongoing Covid-19 pandemic has raised a Series A, the startup’s CEO confirmed to Endpoints...